RECENT NEWS

From cancer to birth defects to infectious disease, modern gene and bioanalysis is the key to personalised medicine.

One in eight people who were hospitalised with COVID-19 between May 2020 and March 2021 were later diagnosed with myocarditis, or heart inflammation, according to major new research into the clinical long-term effects of COVID-19.

Indica Labs, a provider of computational pathology software and services, has announced a CE-IVD mark for HALO Prostate AI, a screening tool designed to assist pathologists in identifying and grading prostate cancer in needle biopsies.

A research team at the University of Bayreuth has been taking advantage of the most popular pipette controller, INTEGRA’s PIPETBOY acu 2, for the preparation of buffers, media and samples in its cell culture workflows.

Pneumagen, a clinical-stage biotechnology company developing Neumifil, a broad-spectrum antiviral intranasal drug, has reported positive topline data from a phase 1 study designed to evaluate safety and tolerability in healthy volunteers.

There are a number of infectious diseases of humans that result in specific antigens being excreted into the urine during infection. Often these antigens are glycans/carbohydrates originating from bacterial/fungal LPS or cell wall polysaccharides.

Diagnostica Medica and Proteomedix, the Swiss cancer diagnostics company, have announced that Proclarix , a new blood test for the management of prostate cancer patients, has been introduced in the routine of the laboratory.

Maternal obesity impairs heart health and function of the fetus according to a new study in mice.

Labelling samples accurately in a laboratory environment requires overcoming many challenges such as xylene and acetone exposure, extreme temperatures, and relying on robust solvent compatibility.

Creating the industry’s first stem cell analysis update in nearly 25 years, Beckman Coulter Life Sciences has launched an evolution of the gold-standard in haematopoietic stem cell enumeration, the AQUIOS STEM system.

Evonetix, the synthetic biology company bringing semiconductor technology to DNA synthesis, has been granted a European patent covering its Binary Assembly method for gene synthesis.

Avacta Group has announced that the company has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.

The Academy of Medical Sciences has elected 60 outstanding biomedical and health scientists to its influential Fellowship, it has been announced.

Biotium, a supplier of cutting-edge life science reagents, has announcing the acquisition of Cell Data Sciences RNAstorm and DNAstorm kits for RNA/DNA extraction.

The pathology service at The Princess Alexandra Hospital NHS Trust (PAHT) in Harlow has introduced the CliniSys Integrated Clinical Environment (ICE) sample collection module to improve efficiency and experiences for their patients and staff.

A contract for the implementation of a new laboratory information management system (LIMS) across all NHS pathology services in Lancashire and South Cumbria has been awarded to Citadel Health.

BIVDA, the UK’s in vitro diagnostics trade association, has commented on the passing of the Health and Care Bill into law, which took place recently.

Following the postponement of the 2020 and 2021 in-person events, SHOT has announced that registration and abstract submission for the IHN-SHOT Symposium 2022 is now open!

Tecan has launched the MagicPrep NGS, an automated benchtop library preparation system that transforms time-consuming and error-prone procedures into a simple, robust experience.

Enough has been said about how the diagnostics community has been central to the response to the pandemic, but it does not do justice to the facts behind diagnostics and why we must not let this moment slip through our fingers, says David Wells.